Maintenance of Gains, Morbidity, and Mortality at 1 Year Following Cardiac Rehabilitation in a Middle-Income Country: A Wait-List Control Crossover Trial

Gabriela S S Chaves, Gabriela Lima de Melo Ghisi, Raquel R Britto, Sherry L Grace, Gabriela S S Chaves, Gabriela Lima de Melo Ghisi, Raquel R Britto, Sherry L Grace

Abstract

Background Despite the epidemic of cardiovascular diseases in middle-income countries, few trials are testing the benefits of cardiac rehabilitation ( CR ). This trial assessed (1) maintenance of functional capacity, risk factor control, knowledge, and heart-health behaviors and (2) mortality and morbidity at 6 months following CR in a middle-income country. Methods and Results Eligible Brazilian coronary patients were initially randomized (1:1:1 concealed) to 1 of 3 parallel arms (comprehensive CR [exercise plus education], exercise-only CR , or wait-list control). The CR programs were 6 months in duration, at which point follow-up assessments were performed. Mortality and morbidity were ascertained from chart and patient or family report (blinded). Controls were then offered CR (crossover). Outcomes were again assessed 6 months later (blinded). ANCOVA was performed for each outcome at 12 months. Overall, 115 (88.5%) patients were randomized, and 62 (53.9%) were retained at 1 year. At 6 months, 23 (58.9%) of those 39 initially randomized to the wait-list control elected to attend CR . Functional capacity, risk factors, knowledge, and heart-health behaviors were maintained from 6 to 12 months in participants from both CR arms (all P>0.05). At 1 year, knowledge was significantly greater with comprehensive CR at either time point ( P<0.001). There were 2 deaths. Hospitalizations ( P=0.03), nonfatal myocardial infarctions ( P=0.04), and percutaneous coronary interventions ( P=0.03) were significantly fewer with CR than control at 6 months. Conclusions CR participation is associated with lower morbidity, long-term maintenance of functional capacity, risk factors, and heart-health behaviors, as well as with greater cardiovascular knowledge compared with no CR . Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT 02575976.

Trial registration: ClinicalTrials.gov NCT02575976.

Keywords: cardiac rehabilitation; coronary disease; morbidity/mortality; rehabilitation; risk factor.

Figures

Figure 1
Figure 1
Study flow diagram. The threshold number of sessions for per‐protocol analysis was minimum of 24 of 36 exercise sessions (both CR arms) and an additional 16 of 24 education classes for comprehensive CR. CR indicates cardiac rehabilitation.
Figure 2
Figure 2
Mortality and morbidity by arm and time. The threshold number of sessions for per‐protocol analysis was minimum of 24of 36 exercise sessions (both CR arms) and an additional 16 of 24 education classes for CCR. Least significant difference post hoc: *§P<0.05; **P<0.01. CABG indicates coronary artery bypass grafting; CCR, comprehensive cardiac rehabilitation; CR, cardiac rehabilitation; CV, cardiovascular; Dept, department; MI, myocardial infarction; PCI, percutaneous coronary intervention.

References

    1. World Health Organization . Global Status Report on Noncommunicable Diseases. Geneva: WHO; 2014. Available at: . Accessed October 07, 2018.
    1. Brasil Ministério da Saúde . Sistema de Informações de Mortalidade SIM e IBGM. 2014. Available at: . Accessed October 06, 2018.
    1. Grace SL, Turk‐Adawi KI, Contractor A, Atrey A, Campbell N, Derman W, Melo Ghisi GL, Oldridge N, Sarkar BK, Yeo TJ, Lopez‐Jimenez F, Mendis S, Oh P, Hu D, Sarrafzadegan N. Cardiac rehabilitation delivery model for low‐resource settings. Heart. 2016;102:1449–1455.
    1. British Association for Cardiovascular Prevention and Rehabilitation . The BACPR Standards and Core Components for Cardiovascular Disease Prevention and Rehabilitation 2017. 3rd ed London: British Cardiovascular Society; 2017. Available at: . Accessed December 14, 2018.
    1. Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, Taylor RS. Exercise‐based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2016;1:CD001800.
    1. Powell R, McGregor G, Ennis S, Kimani PK, Underwood M. Is exercise‐based cardiac rehabilitation effective? A systematic review and meta‐analysis to re‐examine the evidence. BMJ Open. 2018;8:e019656.
    1. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S; PURE Investigators‐Writing Group . The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low‐, middle‐, and high‐income countries. Am Heart J. 2009;158:1–7.e1.
    1. Chaves GSS, Ghisi GLM, Grace SL, Oh P, Ribeiro AL, Britto RR. Effects of comprehensive cardiac rehabilitation on functional capacity and cardiovascular risk factors in Brazilians assisted by public health care: protocol for a randomized controlled trial. Braz J Phys Ther. 2016;20:592–600.
    1. Chaves GSS, Ghisi GLM, Grace SL, Oh P, Ribeiro AL, Britto RR. Comprehensive cardiac rehabilitation in a middle‐income setting: a randomized trial. Heart. 2018. Available at: . Accessed February 8, 2019.
    1. Turk‐Adawi K, Supervia Pola M, Lopez Jimenez F, Pesah E, Rongjing D, Britto R, Bjarnason‐Wehrens B, Derman W, Abreu A, Grace SL; on behalf of ICCPR Working Group . Cardiac rehabilitation availability and density around the globe. World Congress of Cardiology & Cardiovascular Health Dubai, United Arab Emirates. December. (moderated poster). Glob Heart. 2018;13:381.
    1. Herdy AH, Lopez‐Jimenez F, Terzic CP, Milani M, Stein R, Carvalho T, Serra S, Araujo CG, Zeballos PC, Anchique CV, Burdiat G, Gonzalez K, Fernandez R, Santibanez C, Rodriguez‐Escudero JP, Ilarraza‐Lomeli H. South American guidelines for cardiovascular disease prevention and rehabilitation. Arq Bras Cardiol. 2014;103:1–31.
    1. Ghisi GLM, Scane K, Sandison N, Maksymiu S, Skeffington V, Oh P. Development of an educational curriculum for cardiac rehabilitation patients and their families. J Clin Exp Cardiolog. 2015;6:373.
    1. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47:1019–1024.
    1. National Institutes of Health . Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res. 1998;6:51–209.
    1. Santos IS, Tavares BF, Munhoz TN, Almeida LSP, Silva NTB, Tams BD, Patella AM, Matijasevich A. Sensitivity and specificity of the Patient Health Questionnaire‐9 (PHQ‐9) among adults from the general population. Cad Saude Publica. 2013;29:1533–1543.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ‐9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613.
    1. Ghisi GL, Grace SL, Thomas S, Evans M, Oh P. Development and psychometric validation of the second version of the Coronary Artery Disease Education Questionnaire (CADE‐Q II). Patient Educ Couns. 2015;98:378–383.
    1. Laviolle B, Froger‐Bompas C, Guillo P, Sevestre A, Letellier C, Pouchard M, Daubert JC, Paillard F. Relative validity and reproducibility of a 14‐item semi‐quantitative food frequency questionnaire for cardiovascular prevention. Eur J Cardiovasc Prev Rehabil. 2005;12:587–595.
    1. Bassett DR, John D. Use of pedometers and accelerometers in clinical populations: validity and reliability issues. Phys Ther Rev. 2010;15:135–142.
    1. Schneider PL, Crouter SE, Lukajic O, Bassett DR. Accuracy and reliability of 10 pedometers for measuring steps over a 400‐m walk. Med Sci Sports Exerc. 2003;35:1779–1784.
    1. Crouter SE, Schneider PL, Karabulut M, Bassett DR. Validity of 10 electronic pedometers for measuring steps, distance, and energy cost. Med Sci Sports Exerc. 2003;35:1455–1460.
    1. Grace SL, Midence L, Oh P, Brister S, Chessex C, Stewart DE, Arthur HM. Cardiac rehabilitation program adherence and functional capacity among women: a randomized controlled trial. Mayo Clin Proc. 2016;91:140–148.
    1. Tudor‐locke C, Craig CL, Aoyagi Y, Bell RC, Croteau KA, De Bourdeaudhuij I, Ewald B, Gardner AW, Hatano Y, Lutes LD, Matsudo SM, Ramirez‐Marrero FA, Rogers LQ, Rowe DA, Schmidt MD, Tully MA, Schmidt MD. How many steps/day are enough? For older adults and special populations. Int J Behav Nutr Phys Act. 2011;8:1–19.
    1. Ragupathi L, Stribling J, Yakunina Y, Fuster V, McLaughlin MA, Vedanthan R. Availability, use, and barriers to cardiac rehabilitation in LMIC. Glob Heart. 2017;12:323–334.
    1. Shanmugasegaram S, Perez‐Terzic C, Jiang X, Grace SL. Cardiac rehabilitation services in low‐and middle‐income countries: a scoping review. J Cardiovasc Nurs. 2014;29:454–463.
    1. Babu AS, Lopez‐Jimenez F, Thomas RJ, Isaranuwatchai W, Herdy AH, Hoch JS, Grace SL. Advocacy for outpatient cardiac rehabilitation globally. BMC Health Serv Res. 2016;16:471.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir